Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma

To determine the sensitivity and specificity of HPV16 serology as diagnostic marker for HPV16-driven oropharyngeal squamous cell carcinoma (OPSCC), 214 HNSCC patients from Germany and Italy with fresh-frozen tumor tissues and sera collected before treatment were included in this study. Hundred and t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Holzinger, Dana (VerfasserIn) , Herold-Mende, Christel (VerfasserIn) , Dyckhoff, Gerhard (VerfasserIn) , Bosch, Franz X. (VerfasserIn) , Pawlita, Michael (VerfasserIn) , Waterboer, Tim (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 18 March 2017
In: International journal of cancer
Year: 2017, Jahrgang: 140, Heft: 12, Pages: 2748-2757
ISSN:1097-0215
DOI:10.1002/ijc.30697
Online-Zugang:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1002/ijc.30697
Verlag, kostenfrei, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.30697
Volltext
Verfasserangaben:Dana Holzinger, Gunnar Wichmann, Lorena Baboci, Angelika Michel, Daniela Höfler, Manuel Wiesenfarth, Lea Schroeder, Paolo Boscolo‐Rizzo, Christel Herold‐Mende, Gerhard Dyckhoff, Andreas Boehm, Annarosa Del Mistro, Franz X. Bosch, Andreas Dietz, Michael Pawlita and Tim Waterboer

MARC

LEADER 00000caa a2200000 c 4500
001 158046145X
003 DE-627
005 20220814233926.0
007 cr uuu---uuuuu
008 180828s2017 xx |||||o 00| ||eng c
024 7 |a 10.1002/ijc.30697  |2 doi 
035 |a (DE-627)158046145X 
035 |a (DE-576)51046145X 
035 |a (DE-599)BSZ51046145X 
035 |a (OCoLC)1341017800 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 32  |2 sdnb 
100 1 |a Holzinger, Dana  |e VerfasserIn  |0 (DE-588)1022770225  |0 (DE-627)717041573  |0 (DE-576)365932523  |4 aut 
245 1 0 |a Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma  |c Dana Holzinger, Gunnar Wichmann, Lorena Baboci, Angelika Michel, Daniela Höfler, Manuel Wiesenfarth, Lea Schroeder, Paolo Boscolo‐Rizzo, Christel Herold‐Mende, Gerhard Dyckhoff, Andreas Boehm, Annarosa Del Mistro, Franz X. Bosch, Andreas Dietz, Michael Pawlita and Tim Waterboer 
264 1 |c 18 March 2017 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 28.08.2018 
520 |a To determine the sensitivity and specificity of HPV16 serology as diagnostic marker for HPV16-driven oropharyngeal squamous cell carcinoma (OPSCC), 214 HNSCC patients from Germany and Italy with fresh-frozen tumor tissues and sera collected before treatment were included in this study. Hundred and twenty cancer cases were from the oropharynx and 94 were from head and neck cancer regions outside the oropharynx (45 oral cavity, 12 hypopharynx and 35 larynx). Serum antibodies to early (E1, E2, E6 and E7) and late (L1) HPV16 proteins were analyzed by multiplex serology and were compared to tumor HPV RNA status as the gold standard. A tumor was defined as HPV-driven in the presence of HPV16 DNA and HPV16 transformation-specific RNA transcript patterns (E6*I, E1∧E4 and E1C). Of 120 OPSCC, 66 (55%) were HPV16-driven. HPV16 E6 seropositivity was the best predictor of HPV16-driven OPSCC (diagnostic accuracy 97% [95%CI 92-99%], Cohen's kappa 0.93 [95%CI 0.8-1.0]). Of the 66 HPV-driven OPSCC, 63 were HPV16 E6 seropositive, compared to only one (1.8%) among the 54 non-HPV-driven OPSCC, resulting in a sensitivity of 96% (95%CI 88-98) and a specificity of 98% (95%CI 90-100). Of 94 HNSCC outside the oropharynx, six (6%) were HPV16-driven. In these patients, HPV16 E6 seropositivity had lower sensitivity (50%, 95%CI 19-81), but was highly specific (100%, 95%CI 96-100). In conclusion, HPV16 E6 seropositivity appears to be a highly reliable diagnostic marker for HPV16-driven OPSCC with very high sensitivity and specificity, but might be less sensitive for HPV16-driven HNSCC outside the oropharynx. 
650 4 |a biomarker 
650 4 |a diagnosis 
650 4 |a early proteins 
650 4 |a head and neck squamous cell carcinoma 
650 4 |a human papillomavirus 
650 4 |a oropharynx 
650 4 |a serology 
700 1 |a Herold-Mende, Christel  |e VerfasserIn  |0 (DE-588)1022936549  |0 (DE-627)717335577  |0 (DE-576)366194267  |4 aut 
700 1 |a Dyckhoff, Gerhard  |d 1965-  |e VerfasserIn  |0 (DE-588)12114335X  |0 (DE-627)081114346  |0 (DE-576)292556918  |4 aut 
700 1 |a Bosch, Franz X.  |d 1945-  |e VerfasserIn  |0 (DE-588)1077786603  |0 (DE-627)837501016  |0 (DE-576)446672912  |4 aut 
700 1 |a Pawlita, Michael  |e VerfasserIn  |0 (DE-588)1135594724  |0 (DE-627)890509786  |0 (DE-576)489840140  |4 aut 
700 1 |a Waterboer, Tim  |e VerfasserIn  |0 (DE-588)119305494X  |0 (DE-627)1671578821  |4 aut 
773 0 8 |i Enthalten in  |t International journal of cancer  |d Bognor Regis : Wiley-Liss, 1966  |g 140(2017), 12, Seite 2748-2757  |h Online-Ressource  |w (DE-627)269532781  |w (DE-600)1474822-8  |w (DE-576)079876129  |x 1097-0215  |7 nnas  |a Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma 
773 1 8 |g volume:140  |g year:2017  |g number:12  |g pages:2748-2757  |g extent:10  |a Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma 
856 4 0 |u http://dx.doi.org/10.1002/ijc.30697  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.30697  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20180828 
993 |a Article 
994 |a 2017 
998 |g 119305494X  |a Waterboer, Tim  |m 119305494X:Waterboer, Tim  |d 140000  |e 140000PW119305494X  |k 0/140000/  |p 16  |y j 
998 |g 1135594724  |a Pawlita, Michael  |m 1135594724:Pawlita, Michael  |d 140000  |e 140000PP1135594724  |k 0/140000/  |p 15 
998 |g 1077786603  |a Bosch, Franz X.  |m 1077786603:Bosch, Franz X.  |d 50000  |e 50000PB1077786603  |k 0/50000/  |p 13 
998 |g 12114335X  |a Dyckhoff, Gerhard  |m 12114335X:Dyckhoff, Gerhard  |d 910000  |d 911000  |e 910000PD12114335X  |e 911000PD12114335X  |k 0/910000/  |k 1/910000/911000/  |p 10 
998 |g 1022936549  |a Herold-Mende, Christel  |m 1022936549:Herold-Mende, Christel  |d 910000  |d 911200  |d 50000  |e 910000PH1022936549  |e 911200PH1022936549  |e 50000PH1022936549  |k 0/910000/  |k 1/910000/911200/  |k 0/50000/  |p 9 
999 |a KXP-PPN158046145X  |e 3024067191 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"note":["Gesehen am 28.02.08","Darin: Predictive oncology"],"titleAlt":[{"title":"Predictive oncology"}],"pubHistory":["1.1966 -"],"id":{"issn":["1097-0215"],"doi":["10.1002/(ISSN)1097-0215"],"eki":["269532781"],"zdb":["1474822-8"]},"origin":[{"publisher":"Wiley-Liss","dateIssuedDisp":"1966-","publisherPlace":"Bognor Regis","dateIssuedKey":"1966"}],"corporate":[{"role":"isb","display":"International Union against Cancer"}],"disp":"Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinomaInternational journal of cancer","title":[{"subtitle":"publication of the International Union against Cancer (UICC) = Journal international du cancer","title_sort":"International journal of cancer","title":"International journal of cancer"}],"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"269532781","titleTranslated":[{"translated":"Journal international du cancer"}],"physDesc":[{"extent":"Online-Ressource"}],"part":{"text":"140(2017), 12, Seite 2748-2757","volume":"140","year":"2017","pages":"2748-2757","issue":"12","extent":"10"}}],"title":[{"title_sort":"Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma","title":"Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma"}],"physDesc":[{"extent":"10 S."}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"158046145X","id":{"eki":["158046145X"],"doi":["10.1002/ijc.30697"]},"name":{"displayForm":["Dana Holzinger, Gunnar Wichmann, Lorena Baboci, Angelika Michel, Daniela Höfler, Manuel Wiesenfarth, Lea Schroeder, Paolo Boscolo‐Rizzo, Christel Herold‐Mende, Gerhard Dyckhoff, Andreas Boehm, Annarosa Del Mistro, Franz X. Bosch, Andreas Dietz, Michael Pawlita and Tim Waterboer"]},"origin":[{"dateIssuedDisp":"18 March 2017","dateIssuedKey":"2017"}],"language":["eng"],"note":["Gesehen am 28.08.2018"],"person":[{"given":"Dana","display":"Holzinger, Dana","family":"Holzinger","role":"aut"},{"display":"Herold-Mende, Christel","role":"aut","family":"Herold-Mende","given":"Christel"},{"display":"Dyckhoff, Gerhard","role":"aut","family":"Dyckhoff","given":"Gerhard"},{"role":"aut","family":"Bosch","display":"Bosch, Franz X.","given":"Franz X."},{"given":"Michael","display":"Pawlita, Michael","family":"Pawlita","role":"aut"},{"given":"Tim","role":"aut","family":"Waterboer","display":"Waterboer, Tim"}]} 
SRT |a HOLZINGERDSENSITIVIT1820